VITROLIFE A/S: Financial statements 2023
CVR: 27406793
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
VITROLIFE A/S (CVR 27406793) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 216,829,286 and a net result of DKK 103,152,563 compared with DKK 107,758,000 the year before. That is a decrease of 1.1% compared with the year before. Equity in the 2023 report amounted to DKK 239,413,886. The solvency ratio was 83.7%. The company had 100 employees in the financial year.
- Gross Profit
- DKK 216,829,286
- Profit/Loss
- DKK 103,152,563
- Equity
- DKK 239,413,886
- Total Assets
- DKK 286,187,145
- Employees
- 100
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 216.8M | 103.2M | 239.4M | 100 |
| 2022 | - | 219.3M | 107.8M | 255.8M | 90 |
| 2021 | - | 194.2M | 96.5M | 247.5M | 86 |
| 2020 | - | 130.4M | 57.3M | 210.6M | 82 |
| 2019 | - | 183M | 94.3M | 153.2M | 81 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
VITROLIFE A/S has published its annual report for 2022. Gross profit came to DKK 219,325,000, and the net result was DKK 107,758,000.
As of March 31, 2023, Tony Patrik Tolf has joined the board of directors of VITROLIFE A/S.
As of March 31, 2023, Hans Thomas Axelsson has left the board of directors of VITROLIFE A/S.
As of March 30, 2023, Tony Patrik Tolf has left the board of directors of VITROLIFE A/S.
About VITROLIFE A/S
VITROLIFE A/S is a Danish company of the type Aktieselskab based in Viby J, founded in 2003. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named UNISENSE FERTILITECH A/S and UNISENSE FERTILITECH ApS. The management consists of Dag Erik Rickard Ericsson. The board consists of Sten Jakob Hedén (chair), Dag Erik Rickard Ericsson and Tom Faes. The company is owned by Vitrolife AB. The company has 114 employees (2026). In 2025, the company reported a gross profit of DKK 228,406,323 and a net result of DKK 110,485,853 compared with DKK 130,285,262 the year before. Equity in the 2025 report amounted to DKK 327,839,900.
